- We are exhibiting at Linus Dagarna together with EMM Life Science AB (LinkedIN)
Växjö, September 19-21, 2023
- We closed our first investment round and raised 7M SEK! 🚀🚀🚀
The investors include ALMI Invest, together with life science angel investors and the Propel Capital. More information can be found in our press releases. (English – Swedish)
May 24, 2023
- We presented results of our clinical performance study at Karolinska University Hospital at ECCMID 2023 (here)
- 22 new companies of Sting are announced in Dagens Industri and UTI-lizer is one of them!
September 7, 2022
- We got support from Vinnova! 🎉🎉🎉
Our preparatory project for international proposal is accepted. We will be setting a multi-center clinical trial for our tests at the point-of-care.
June 13, 2022
- We successfully completed first extensive clinical validation and performance study of our tests at the Karolinska University Hospital! 🚀💯 (post)
June 1, 2022
- UTI-lizer has joined the leading Nordic incubator Sting! 🙌
May 1, 2022
- UTI-lizer has been selected as one of the Hello Tomorrow Deep Tech Pioneers!
September 23, 2021
- UTI-lizer got the EIT Health Wildcard! We have participated in EIT Health Wildcard Hackathon.
July 1-10, 2020